Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis

Author(s): Rohit Sharma, Amanpreet Kaur, A. K. Sharma, Neeraj Dilbaghi, Anil K. Sharma

Journal Name: Current Drug Targets

Volume 18 , Issue 1 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Nanotechnology has shown great promise in health care offering numerous possibilities to significantly improve diagnosis of many dreadful diseases including Tuberculosis (TB). Nanomedicine has made the current drug regimen more effective against diseases particularly TB with attributes like sustained release, increased half life, higher drug concentrations at target sites, reduced toxicity and lesser side effects. However because of the severity of the disease, there is a strong urge to develop better approaches with some concomitant regimens using nano-particles to diagnose, treat and manage TB patients. The current review highlights some of the evolving strategies in the field of nanomedicine particularly drug delivery offering promising alternative for the current TB regimens. The study also emphasizes upon the need to design more effective nanocarriers which are highly specific, biocompatible and biodegradable as well.

Keywords: Nanomedicine, TB, nanocarriers, drugs, drug regimen.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 01 December, 2016
Page: [72 - 86]
Pages: 15
DOI: 10.2174/1389450116666150804110238
Price: $65

Article Metrics

PDF: 37